< Back to Article

A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors

Fig 2

Effect of DXS concentration on the rate of FXII activation.

doi: https://doi.org/10.1371/journal.pcbi.1012552.g002